Article Text

Download PDFPDF
How sweet it isn't: a new formulation of sodium phenylbutyrate and the challenge of palatability for medicines for children
  1. Michael Rieder
  1. Departments of Paediatrics, Physiology and Pharmacology, Medicine, Robarts Research Institute, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada
  1. Correspondence to Dr Michael Rieder, Department of Paediatrics, Children's Hospital, 800 Commissioner's Road East, London, Ontario, Canada, N6C 2V5; mrieder{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The development of medications for children presents unique challenges that test the ingenuity of investigators and industry in their search for drugs that are safe, effective – and can be taken by children. One of the most telling challenges relates to palatability. Children – especially under the age of 5 – usually require medication to be in a liquid form, and as medications are typically bitter, children may find this to be, as one might say, a difficult thing to swallow. While this area has been historically understudied, recent work has clearly established that this is an important concern with clear implications for adherence and, ultimately, therapeutic efficacy.1–3

Guffon et al4 describe a series of studies exploring a …

View Full Text


  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.